Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantQuality of LifeCombined Modality TherapyAntineoplastic AgentsCisplatinTreatment OutcomeCyclophosphamideDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelVinblastineInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsLifeIfosfamideDrug Resistance, NeoplasmBleomycinFollow-Up StudiesDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticNeoplasmsAnthracyclinesAntineoplastic Agents, AlkylatingTime FactorsChemotherapy, Cancer, Regional PerfusionCytarabineCarcinoma, Non-Small-Cell LungSalvage TherapyOvarian NeoplasmsNeoplasm MetastasisProspective StudiesTesticular NeoplasmsVomitingNauseaTransplantation, AutologousAdenocarcinomaNeutropeniaLymphoma, Non-HodgkinRadiotherapy, AdjuvantAntineoplastic Agents, PhytogenicHodgkin DiseaseRadiotherapyColorectal NeoplasmsClinical Trials as TopicAntibiotics, AntineoplasticDacarbazineNeoplasms, Germ Cell and EmbryonalCarmustineKaplan-Meier EstimateLomustinePalliative CareGranulocyte Colony-Stimulating FactorBrain NeoplasmsCamptothecinPlatinum CompoundsBone NeoplasmsOsteosarcomaInfusions, Intra-ArterialAntiemeticsMelphalanMitomycinLeukopeniaRecurrenceDrug TherapyLiver NeoplasmsHematopoietic Stem Cell TransplantationThiotepaTumor Markers, BiologicalDose-Response Relationship, DrugPeritoneal NeoplasmsMitoxantroneLife TablesInfusions, IntravenousStomach NeoplasmsLymphatic MetastasisAntibodies, Monoclonal, HumanizedTegafurRandomized Controlled Trials as TopicRadiotherapy DosageCell Line, TumorGerminomaDisease ProgressionDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma